Yvonne Greenstreet Transfers Shares of Alnylam Pharmaceuticals Inc (ALNY) — SEC Form 4, Nov 17, 2026

SEC Form 4 · No Market Transaction
Gift

Transfer of shares as a gift.

Reporting Owner
TXN 2026-11-13 · FILED 2026-11-17
Equity Position 85.2K sh 96,209 → 85,209
Equity Change -11.4% shares held after vs before
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2026-11-17
Report Date
2026-11-17
Accession No.
0001178670-26-000091
Accepted At
2026-11-17 21:06 UTC
Reporting Owner
Name Relationship
Yvonne Greenstreet CIK 0001446125
Director CEO
Yvonne Greenstreet at Alnylam Pharmaceuticals Inc Full insider history
Bought (12 mo) —
Sold (12 mo) $8,807,978
More from this insider at Alnylam Pharmaceuticals Inc
2026-09-22 Award — View
2026-03-06 Sell -$947,581 View
2026-03-05 Sell -$2,227,698 View
2026-03-02 Exercise — View
2026-02-18 Sell -$2,157,542 View
All filings by this insider at Alnylam Pharmaceuticals Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1 2026-11-13 G - Gift 11,000 D $0.00 — 84,802 Direct
Non-Derivative Holdings
Title Shares Held Ownership
Common StockF2 407 Indirect by Managed Account
Footnotes (2)
F1
The reported transaction involves a transfer of securities by bona fide gift for estate planning purposes to the Yvonne Greenstreet 2024 Irrevocable Trust Dtd 10/29/2024, of which the reporting person is neither the trustee nor a beneficiary. Show more
F2
Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. Show more
5%+ Holders · 13D/G 6 filers
Other insiders at Alnylam Pharmaceuticals Inc
All Alnylam Pharmaceuticals Inc insider activity
GET /v1/forms/4/0001178670-26-000091 API docs
View Original SEC Filing